BALYASNY ASSET MANAGEMENT L.P. - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 228 filers reported holding SAGE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$1,324,000
-87.8%
33,794
-89.9%
0.00%
-88.6%
Q2 2022$10,842,000
+1599.4%
335,666
+1641.4%
0.04%
+1650.0%
Q1 2022$638,000
+44.0%
19,276
+92.8%
0.00%0.0%
Q3 2021$443,000
-97.5%
10,000
-96.6%
0.00%
-98.5%
Q3 2020$17,865,000
+3166.0%
292,289
+1435.3%
0.13%
+2083.3%
Q1 2020$547,000
-95.0%
19,038
-87.5%
0.01%
-90.8%
Q4 2019$11,009,000
-28.4%
152,505
-5.0%
0.06%
-41.4%
Q4 2018$15,374,000
-6.7%
160,500
+38.8%
0.11%
+50.0%
Q3 2018$16,471,000
+639.3%
115,593
+712.3%
0.07%
+640.0%
Q2 2018$2,228,000
-95.7%
14,231
-95.5%
0.01%
-95.3%
Q1 2018$51,242,000
-54.7%
318,131
-53.6%
0.21%
-39.4%
Q4 2017$113,024,000
+236.1%
686,200
+27.1%
0.35%
+167.4%
Q3 2017$33,630,000
-35.1%
539,802
-17.0%
0.13%
-38.3%
Q2 2017$51,805,000
+45.1%
650,500
+29.5%
0.21%
+28.9%
Q1 2017$35,702,000
+85.3%
502,343
+33.1%
0.17%
+59.6%
Q4 2016$19,268,000
+81.9%
377,360
+64.1%
0.10%
+70.5%
Q3 2016$10,592,000
+214.1%
230,006
+105.5%
0.06%
+177.3%
Q2 2016$3,372,000
+120.4%
111,909
+326.3%
0.02%
+100.0%
Q4 2015$1,530,00026,2500.01%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Integral Health Asset Management, LLC 311,000$10,294,0002.68%
Palo Alto Investors LP 851,719$28,192,0002.18%
Boxer Capital, LLC 1,094,000$36,211,0001.86%
DAFNA Capital Management LLC 180,306$5,968,0001.56%
Deep Track Capital, LP 675,000$22,343,0001.43%
Bellevue Group AG 3,052,404$101,034,0001.17%
Ikarian Capital, LLC 249,907$8,272,0001.09%
Ikarian Capital, LLC 250,000$8,275,0001.09%
Artal Group S.A. 750,000$24,825,0001.04%
SECTOR GAMMA AS 118,476$3,922,0000.85%
View complete list of SAGE THERAPEUTICS INC shareholders